Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated escalating doses of romidepsin in combination with CHOP for Peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms [Phase 2]
Phase 2 trial evaluating bevacizumab with combination chemotherapy for peripheral T-cell lymphoma and natural killer cell neoplasms has comp…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating the combination of bortezomib and azacitidine in adults with relapsed or refractory T-cell lymphomas; the trial is …
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating CHO(E)P-14 chemotherapy followed by alemtuzumab consolidation …
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pralatrexate and gemcitabine with B12 and folic acid in relapsed/refractory lymphoproliferative malignan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL [Phase 1]
Phase I study of KW-0761 (mogamulizumab) in relapsed CCR4-positive adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma; results ha…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma [Phase 2]
Phase 2 trial evaluating intensive chemo-immunotherapy as first-line treatment in adults with peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients [Phase 2]
A Phase 2 trial evaluating lenalidomide in relapsed/refractory peripheral T-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma [Phase 2]
A Phase 2 clinical trial of romidepsin for progressive or relapsed peripheral T-cell lymphoma has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas [EARLY_Phase 1]
An early-phase 1 study of lenalidomide in relapsed and/or refractory peripheral T-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL) [Phase 2]
Phase 2 trial assessing the effectiveness of adding alemtuzumab to CHOP and ESHAP regimens in newly diagnosed Peripheral T-cell lymphoma; th…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT [Phase 2]
This completed Phase II trial in peripheral T-cell lymphoma evaluated dose-intensive induction followed by high-dose consolidation with auto…
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma [Phase 2]
Phase 2 trial update evaluating Endostar in combination with CHOP as first-line chemotherapy for peripheral T cell lymphoma; no results are …
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 2]
A Phase 2 trial evaluating pralatrexate with vitamins B12 and folic acid in relapsed or refractory peripheral T-cell lymphoma has completed …
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma [NA]
The LAMPP trial studying peripheral and cutaneous T-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas [Phase 1, Phase 2]
A completed Phase 1/2 clinical study evaluated combining bortezomib with CHOP chemotherapy in patients with advanced aggressive T-cell lymph…
-
CLINICAL_TRIALS trial_result · 2009-09-09Clinical Trial Update: Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating treatment for newly diagnosed non-cutaneous peripheral T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL [Phase 2]
Phase 2 trial evaluating the effectiveness of alemtuzumab combined with CHOP in newly diagnosed peripheral T-cell lymphoma; the study status…